Related Experiment Video
Updated: Jan 19, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
Published on: February 9, 2011
Methicillin-Resistant Staphylococcus aureus Infection and Treatment Options
Sarah J Chalmers1, Mark E Wylam2
1Division of Pulmonary and Critical Care Medicine, Mayo Clinic College of Medicine, Rochester, MN, USA.
Abstract:
Methicillin-resistant Staphylococcus aureus (MRSA) is a leading cause of infection worldwide, including a wide array of both hospital- and community-acquired infections-most commonly bacteremia, upper and lower respiratory tract infection, skin and soft-tissue infection, osteomyelitis, and septic arthritis. This chapter describes the epidemiology of MRSA infection, its ability to confer antibiotic resistance and produce a wide array of virulence factors, and its pivotal role in human infection, especially cystic fibrosis. It also provides an introduction to the strategies for treatment of both chronic and acute MRSA infections.
More Related Videos
Related Concept Videos
12:18Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
08:32Development and Assessment of Intracellular Infection Models for Staphylococcus aureus
09:03Multiplex PCR Assay for Typing of Staphylococcal Cassette Chromosome Mec Types I to V in Methicillin-resistant Staphylococcus aureus
07:32Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus (MRSA) Infection
14:04Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
09:15A Mouse Model to Assess Innate Immune Response to Staphylococcus aureus Infection

